Literature DB >> 11561048

Late presentation of Nipah virus encephalitis and kinetics of the humoral immune response.

S C Wong1, M H Ooi, M N Wong, P H Tio, T Solomon, M J Cardosa.   

Abstract

Nipah virus is a newly discovered paramyxovirus transmitted directly from pigs to humans. During a large encephalitis outbreak in Malaysia and Singapore in 1998-9, most patients presented acutely. A 12 year old child is described who developed encephalitis 4 months after exposure to the virus. She was diagnosed by a new indirect IgG enzyme linked immunosorbent assay (ELISA), which is also described. The late presentation and IgG subclass responses had similarities to subacute sclerosing panencephalitis. Nipah virus should be considered in patients with encephalitis even months after their possible exposure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561048      PMCID: PMC1763511          DOI: 10.1136/jnnp.71.4.552

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

Review 1.  The immune response to Nipah virus infection.

Authors:  Joseph Prescott; Emmie de Wit; Heinz Feldmann; Vincent J Munster
Journal:  Arch Virol       Date:  2012-06-06       Impact factor: 2.574

2.  Nipah virus: vaccination and passive protection studies in a hamster model.

Authors:  V Guillaume; H Contamin; P Loth; M-C Georges-Courbot; A Lefeuvre; P Marianneau; K B Chua; S K Lam; R Buckland; V Deubel; T F Wild
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster Model.

Authors:  Sarah C Genzer; Stephen R Welch; Florine E M Scholte; Jessica R Harmon; JoAnn D Coleman-McCray; Michael K Lo; Joel M Montgomery; Stuart T Nichol; Christina F Spiropoulou; Jessica R Spengler
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

4.  Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.

Authors:  Michael K Lo; Friederike Feldmann; Joy M Gary; Robert Jordan; Roy Bannister; Jacqueline Cronin; Nishi R Patel; John D Klena; Stuart T Nichol; Tomas Cihlar; Sherif R Zaki; Heinz Feldmann; Christina F Spiropoulou; Emmie de Wit
Journal:  Sci Transl Med       Date:  2019-05-29       Impact factor: 17.956

5.  Hendra virus and Nipah virus animal vaccines.

Authors:  Christopher C Broder; Dawn L Weir; Peter A Reid
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

6.  A short communication of Nipah virus outbreak in India: An urgent rising concern.

Authors:  Olivier Uwishema; Jack Wellington; Christin Berjaoui; Kamsi Olivia Muoka; Chinyere Vivian Patrick Onyeaka; Helen Onyeaka
Journal:  Ann Med Surg (Lond)       Date:  2022-09-08

7.  Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.

Authors:  Alexander N Freiberg; Melissa N Worthy; Benhur Lee; Michael R Holbrook
Journal:  J Gen Virol       Date:  2009-11-04       Impact factor: 3.891

Review 8.  Animal models of disease shed light on Nipah virus pathogenesis and transmission.

Authors:  Emmie de Wit; Vincent J Munster
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

9.  Vaccines to Emerging Viruses: Nipah and Hendra.

Authors:  Moushimi Amaya; Christopher C Broder
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

10.  Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route.

Authors:  Vincent J Munster; Joseph B Prescott; Trenton Bushmaker; Dan Long; Rebecca Rosenke; Tina Thomas; Dana Scott; Elizabeth R Fischer; Heinz Feldmann; Emmie de Wit
Journal:  Sci Rep       Date:  2012-10-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.